Revive Therapeutics Ltd.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RVV.CN research report →
Companywww.revivethera.com
Revive Therapeutics Ltd. , a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases.
- CEO
- Michael Frank
- IPO
- 2013
- Employees
- 2
- HQ
- Toronto, ON, CA
Price Chart
Valuation
- Market Cap
- $17.43M
- P/E
- -1.63
- P/S
- 0.00
- P/B
- -4.66
- EV/EBITDA
- -1.63
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 899.59%
- ROIC
- 36.60%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-11,011,319 · -95.98%
- EPS
- $-0.03 · -77.03%
- Op Income
- $-1,648,714
- FCF YoY
- 75.46%
Performance & Tape
- 52W High
- $0.08
- 52W Low
- $0.01
- 50D MA
- $0.04
- 200D MA
- $0.02
- Beta
- -1.83
- Avg Volume
- 658.76K
Get TickerSpark's AI analysis on RVV.CN
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RVV.CN Coverage
We haven't published any research on RVV.CN yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RVV.CN Report →